BioSyent Releases First Quarter 2015 Results - Sales Up 35%; Pharma Sales Up 38%; Ebitda up 92%; Diluted EPS $0.07, Up 75%; Net Income Up 88% http://finance.yahoo.com/news/biosyent-releases-first-quarter-2015-120000766.html